References
- George JN. Platelets. Lancet 2000; 355: 1531–1539
- Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, Levi R. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: Implications for ischemic vascular diseases. J Pharmacol Exp Ther 2003; 305: 9–16
- Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol 2007; 35: 495–516
- Bertino AM, Qi XQ, Li J, Xia Y, Kuter DJ. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 2003; 43: 857–866
- Tonon G, Luo X, Greco NJ, Chen W, Shi Y, Jamieson GA. Weak platelet agonists and U46619 induce apoptosis-like events in platelets, in the absence of phosphatidylserine exposure. Thromb Res 2002; 107: 345–350
- Leytin V, Allen DJ, Mykhaylov S, Mis L, Lyubimov EV, Garvey B, Freedman J. Pathologic high shear stress induces apoptosis events in human platelets. Biochem Biophys Res Commun 2004; 320: 303–310
- Piguet PF, Vesin C, Da Kan C. Activation of platelet caspases by TNF and its consequences for kinetics. Cytokine 2002; 18: 222–230
- Sheu JR, Lee CR, Lin CC, Kan YC, Lin CH, Hung WC, Lee YM, Yen MH. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase. Br J Pharmacol 1999; 127: 1206–1212
- Shcherbina A, Remold-O'Donnell E. Role of caspase in a subset of human platelet activation responses. Blood 1999; 93: 4222–4231
- Hsiao G, Huang HY, Fong TH, Shen MY, Lin CH, Teng CM, Sheu JR. Inhibitory mechanisms of YC-1 and PMC in the induction of iNOS expression by lipoteichoic acid in RAW 264.7 macrophages. Biochem Pharmacol 2004; 67: 1411–1419
- Lopez JJ, Redondo PC, Salido GM, Pariente, JA, Rosado JA. N,N,N′N′-tetrakis(2-pyridylmethyl)ethylenediamine induced apoptosis through the activation of caspase-3 and -8 in human platelets. A role for endoplasmic reticulum stress. J Thromb Haemost 2009; 7: 992–999
- Kagan VE, Borisenko GG, Serinkan BF, Tyurina YY, Tyurin VA, Jiang J, Liu SX, Shvedova AA, Fabisiak JP, Uthaisang W, Fadeel B. Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine. Am J Physiol Lung Cell Mol Physiol 2003; 285: L1–17
- Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombin-triggered platelet apoptosis. J Thromb Haemost 2006; 4: 2656–2663
- Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med 2005; 11: 725–730
- Khosravi-Far R, Esposti MD. Death receptor signals to mitochondria. Cancer Biol Ther 2004; 3: 1051–1057
- Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A, Kroemer G. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 1996; 157: 512–521
- Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000; 405: 85–90
- Lopez JJ, Salido GM, Gomez-Arteta E, Rosado JA, Pariente JA. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost 2007; 5: 1283–1291
- Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003; 43: 526–535
- Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by csapase 8 mediated the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491–501
- Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15: 2922–2933
- Mann KG, Brummel K, Butenas S. What is all that thrombin for?. J Thromb Haemost 2003; 1: 1504–1514
- Flynn AN, Buret AG. Proteinase-activated receptor 1 (PAR-1) and cell apoptosis. Apoptosis 2004; 9: 729–737
- Pulcinelli FM, Pesciotti M, Pignatelli P, Riondino S, Gazzaniga PP. Concomitant activation of Gi and Gq protein-coupled receptors does not require an increase in cytosolic calcium for platelet aggregation. FEBS Lett 1998; 435: 115–118
- Leytin V, Allen DJ, Mutlu A, Gyulkhandanyan AV, Mykhaylov S, Freedman J. Mitochondrial control of platelet apoptosis: Effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest 2009; 89: 374–384